These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

949 related articles for article (PubMed ID: 33973262)

  • 1. ACE2-based decoy receptors for SARS coronavirus 2.
    Jing W; Procko E
    Proteins; 2021 Sep; 89(9):1065-1078. PubMed ID: 33973262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High activity of an affinity-matured ACE2 decoy against Omicron SARS-CoV-2 and pre-emergent coronaviruses.
    Sims JJ; Lian S; Meggersee RL; Kasimsetty A; Wilson JM
    PLoS One; 2022; 17(8):e0271359. PubMed ID: 36006993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a Novel ACE2-Based Therapeutic with Enhanced Rather than Reduced Activity against SARS-CoV-2 Variants.
    Ferrari M; Mekkaoui L; Ilca FT; Akbar Z; Bughda R; Lamb K; Ward K; Parekh F; Karattil R; Allen C; Wu P; Baldan V; Mattiuzzo G; Bentley EM; Takeuchi Y; Sillibourne J; Datta P; Kinna A; Pule M; Onuoha SC
    J Virol; 2021 Sep; 95(19):e0068521. PubMed ID: 34287040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-guided glyco-engineering of ACE2 for improved potency as soluble SARS-CoV-2 decoy receptor.
    Capraz T; Kienzl NF; Laurent E; Perthold JW; Föderl-Höbenreich E; Grünwald-Gruber C; Maresch D; Monteil V; Niederhöfer J; Wirnsberger G; Mirazimi A; Zatloukal K; Mach L; Penninger JM; Oostenbrink C; Stadlmann J
    Elife; 2021 Dec; 10():. PubMed ID: 34927585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. David versus goliath: ACE2-Fc receptor traps as potential SARS-CoV-2 inhibitors.
    Alfaleh MA; Zawawi A; Al-Amri SS; Hashem AM
    MAbs; 2022; 14(1):2057832. PubMed ID: 35380919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin-Converting Enzyme 2 (ACE2) in the Pathogenesis of ARDS in COVID-19.
    Kuba K; Yamaguchi T; Penninger JM
    Front Immunol; 2021; 12():732690. PubMed ID: 35003058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An engineered decoy receptor for SARS-CoV-2 broadly binds protein S sequence variants.
    Chan KK; Tan TJC; Narayanan KK; Procko E
    Sci Adv; 2021 Feb; 7(8):. PubMed ID: 33597251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineering ACE2 decoy receptors to combat viral escapability.
    Arimori T; Ikemura N; Okamoto T; Takagi J; Standley DM; Hoshino A
    Trends Pharmacol Sci; 2022 Oct; 43(10):838-851. PubMed ID: 35902282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineered ACE2 receptor traps potently neutralize SARS-CoV-2.
    Glasgow A; Glasgow J; Limonta D; Solomon P; Lui I; Zhang Y; Nix MA; Rettko NJ; Zha S; Yamin R; Kao K; Rosenberg OS; Ravetch JV; Wiita AP; Leung KK; Lim SA; Zhou XX; Hobman TC; Kortemme T; Wells JA
    Proc Natl Acad Sci U S A; 2020 Nov; 117(45):28046-28055. PubMed ID: 33093202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. V367F Mutation in SARS-CoV-2 Spike RBD Emerging during the Early Transmission Phase Enhances Viral Infectivity through Increased Human ACE2 Receptor Binding Affinity.
    Ou J; Zhou Z; Dai R; Zhang J; Zhao S; Wu X; Lan W; Ren Y; Cui L; Lan Q; Lu L; Seto D; Chodosh J; Wu J; Zhang G; Zhang Q
    J Virol; 2021 Jul; 95(16):e0061721. PubMed ID: 34105996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutralization of SARS-CoV-2 spike pseudotyped virus by recombinant ACE2-Ig.
    Lei C; Qian K; Li T; Zhang S; Fu W; Ding M; Hu S
    Nat Commun; 2020 Apr; 11(1):2070. PubMed ID: 32332765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 receptor binding domain fusion protein efficiently neutralizes virus infection.
    Chaouat AE; Achdout H; Kol I; Berhani O; Roi G; Vitner EB; Melamed S; Politi B; Zahavy E; Brizic I; Lenac Rovis T; Alfi O; Wolf D; Jonjic S; Israely T; Mandelboim O
    PLoS Pathog; 2021 Dec; 17(12):e1010175. PubMed ID: 34929007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular basis for higher affinity of SARS-CoV-2 spike RBD for human ACE2 receptor.
    Delgado JM; Duro N; Rogers DM; Tkatchenko A; Pandit SA; Varma S
    Proteins; 2021 Sep; 89(9):1134-1144. PubMed ID: 33864655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression in humans of the viral entry receptor ACE2 compared with the short deltaACE2 isoform lacking SARS-CoV-2 binding sites.
    Williams TL; Strachan G; Macrae RGC; Kuc RE; Nyimanu D; Paterson AL; Sinha S; Maguire JJ; Davenport AP
    Sci Rep; 2021 Dec; 11(1):24336. PubMed ID: 34934117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A super-potent tetramerized ACE2 protein displays enhanced neutralization of SARS-CoV-2 virus infection.
    Miller A; Leach A; Thomas J; McAndrew C; Bentley E; Mattiuzzo G; John L; Mirazimi A; Harris G; Gamage N; Carr S; Ali H; Van Montfort R; Rabbitts T
    Sci Rep; 2021 May; 11(1):10617. PubMed ID: 34012108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural variations in human ACE2 may influence its binding with SARS-CoV-2 spike protein.
    Hussain M; Jabeen N; Raza F; Shabbir S; Baig AA; Amanullah A; Aziz B
    J Med Virol; 2020 Sep; 92(9):1580-1586. PubMed ID: 32249956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Killing Two Birds with One Stone by Administration of Soluble ACE2: A Promising Strategy to Treat Both Cardiovascular Diseases and SARS-CoV-2 Infection.
    Feng F; Chen J; Zhao J; Li Y; Li M; Sun C
    Viruses; 2021 Nov; 13(11):. PubMed ID: 34835049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2.
    Chan KK; Dorosky D; Sharma P; Abbasi SA; Dye JM; Kranz DM; Herbert AS; Procko E
    Science; 2020 Sep; 369(6508):1261-1265. PubMed ID: 32753553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In silico studies on the comparative characterization of the interactions of SARS-CoV-2 spike glycoprotein with ACE-2 receptor homologs and human TLRs.
    Choudhury A; Mukherjee S
    J Med Virol; 2020 Oct; 92(10):2105-2113. PubMed ID: 32383269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Broadly Effective ACE2 Decoy Proteins Protect Mice from Lethal SARS-CoV-2 Infection.
    Lu M; Yao W; Li Y; Ma D; Zhang Z; Wang H; Tang X; Wang Y; Li C; Cheng D; Lin H; Yin Y; Zhao J; Zhong G
    Microbiol Spectr; 2023 Aug; 11(4):e0110023. PubMed ID: 37395664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.